# A Trial of Nadolol Plus Isosorbide Mononitrate Versus Carvedilol for the Prevention of Variceal Rebleeding

> **NCT01103154** · PHASE4 · COMPLETED · sponsor: **E-DA Hospital** · enrollment: 121 (actual)

## Conditions studied

- Variceal Rebleeding

## Interventions

- **DRUG:** carvedilol
- **DRUG:** nadolol + ISMN

## Key facts

- **NCT ID:** NCT01103154
- **Lead sponsor:** E-DA Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2010-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01103154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01103154, "A Trial of Nadolol Plus Isosorbide Mononitrate Versus Carvedilol for the Prevention of Variceal Rebleeding". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01103154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*